Picture of Pharvaris NV logo

PHVS Pharvaris NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Pharvaris NV expected to post a loss of 56  cents a share - Earnings Preview

* Pharvaris NV  PHVS.OQ   PHVS.O  is expected to show no
change in
quarterly revenue when it reports  results on September 5
(estimated). 
    * ​Refinitiv's mean analyst estimate for Pharvaris NV is for
a
loss of 56 cents per share. For the same quarter last year, the
company reported a loss of 94 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pharvaris
NV is
$22​, above​ its last closing price of $8.99. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in euros). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -0.43       -0.47      -0.48     Missed  -1.6
 Dec. 31 2022  -0.99       -0.72      -0.09     Beat    87.6
 Sep. 30 2021  -0.44       -0.44      -0.39     Beat    11.4​
 Jun. 30 2021  -0.39       -0.42      -0.94     Missed  -122
 ​​Mar.        -0.34       -0.38      -0.66     Missed  -72.5
 31 2021                                                
 Dec. 31 2020  -1.14       -1.14      -2.18     Missed  -90.7​
 This summary was machine generated September 2 at 11:05 GMT. 
All figures in euros  unless otherwise stated

Recent news on Pharvaris NV

See all news